Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Regulatory & Reimbursement

Seeking Reimbursement for AI Tech? Five Things to Remember

Devices driven by artificial intelligence algorithms are becoming more prevalent in healthcare, but reimbursement remains a challenge. Deborah Godes from McDermott+Consulting spoke to Market Pathways on the topic, offering insights for companies entering the coverage, coding, and payment trenches for AI tech in the latest "From the Experts" column.

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Executive Interviews

Nevro Shakes Up SCS: An Interview With Keith Grossman

While most medtech start-ups struggle to gain even single-digit market shares in their efforts against much larger competitors, Nevro has captured one-fifth of the spinal cord stimulation market, through an aggressive clinical trial strategy, novel technology, and the identification of new markets.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More